07/16/2026
Join us on Monday for an upcoming virtual Provider Roundtable focused on the emerging presence of Medetomidine in Kentucky and its implications for member care.
During this educational session, Dr. Michael Frost, Chief Medical Officer at Wayspring, will share insights on this emerging substance, including what Medetomidine is, how it affects individuals, key signs and symptoms of overdose and withdrawal, and trends being observed in other parts of the country.
We look forward to a meaningful discussion and to sharing practical information that can help providers recognize, respond to, and prepare for the evolving challenges associated with Medetomidine. RSVP to the session here: https://info.wayspring.com/providerroundtable
| |